Ameritas Investment Company’s Global Cord Blood Corporation CO Stock Holding History

Ameritas Investment Company’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,024	Closed	-$19K	–	1703
2019 Q3	$19K	Buy	+4,024	New	+$21.1K	﹤0.01%	947
2019 Q1	–	Sell	-7,025	Closed	-$45K	–	2082
2018 Q4	$45K	Buy	+7,025	New	+$44.9K	0.01%	616

Other funds holding CO

JCM

Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Investment Company's CO Position: Q4 2019 in Review

Ameritas Investment Company sold out of Global Cord Blood Corporation (CO) in Q4 2019, closing a stake of 4,024 shares — an estimated $19K sold.

Ameritas Investment Company first reported a position in CO in Q4 2018 and held it in 2 quarters. The position peaked at $45K in Q4 2018. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

Ameritas Investment Company reported no remaining Global Cord Blood Corporation position as of Q4 2019 after selling out during the quarter.
Ameritas Investment Company sold 4,024 Global Cord Blood Corporation shares in Q4 2019, an estimated $19K.
Ameritas Investment Company first reported a position in Global Cord Blood Corporation in Q4 2018 and held it in 2 quarters.
Ameritas Investment Company's Global Cord Blood Corporation position peaked at $45K in Q4 2018.
35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.